Get API key
Insider trading · Q3 2026 · CIK 1711279

Krystal Biotech, Inc. (KRYS) insider trading.

In Q3 2026, insiders at Krystal Biotech, Inc. reported 35 non-derivative transactions on 9 Forms 3, 4 and 5: 0 open-market purchases and 34 sales worth $26.2M.

Transactions
35
Purchases (P)
0
Sales (S)
34
Net shares, P minus S
-75,000
Insiders
3
Last filed
2026-09-04

Insiders

InsiderRelationshipTransactionsBuysSales
Krishnan Krish SDirector, Officer, TenPercentOwner · President and CEO13013
Krishnan SumaDirector, Officer, TenPercentOwner · President, R&D13013
Rossi Dino ADirector908

Transactions

35 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-04Krishnan Krish SS (D)1,358$364.481,348,795Form 4
2026-09-04Krishnan Krish SS (D)847$365.421,347,948Form 4
2026-09-04Krishnan Krish SS (D)405$366.561,347,543Form 4
2026-09-04Krishnan Krish SS (D)520$354.541,372,023Form 4
2026-09-04Krishnan Krish SS (D)2,029$355.571,369,994Form 4
2026-09-04Krishnan Krish SS (D)3,297$356.371,366,697Form 4
2026-09-04Krishnan Krish SS (D)3,981$357.571,362,716Form 4
2026-09-04Krishnan Krish SS (D)3,143$358.421,359,573Form 4
2026-09-04Krishnan Krish SS (D)3,357$359.391,356,216Form 4
2026-09-04Krishnan Krish SS (D)2,266$360.461,353,950Form 4
2026-09-04Krishnan Krish SS (D)1,214$361.611,352,736Form 4
2026-09-04Krishnan Krish SS (D)2,010$362.651,350,726Form 4
2026-09-04Krishnan Krish SS (D)573$363.341,350,153Form 4
2026-09-04Krishnan SumaS (D)1,992$362.651,305,264Form 4
2026-09-04Krishnan SumaS (D)1,242$361.611,307,256Form 4
2026-09-04Krishnan SumaS (D)2,320$360.471,308,498Form 4
2026-09-04Krishnan SumaS (D)3,392$359.391,310,818Form 4
2026-09-04Krishnan SumaS (D)3,180$358.421,314,210Form 4
2026-09-04Krishnan SumaS (D)3,962$357.571,317,390Form 4
2026-09-04Krishnan SumaS (D)565$363.341,304,699Form 4
2026-09-04Krishnan SumaS (D)2,006$355.571,324,619Form 4
2026-09-04Krishnan SumaS (D)520$354.541,326,625Form 4
2026-09-04Krishnan SumaS (D)1,329$364.481,303,370Form 4
2026-09-04Krishnan SumaS (D)826$365.411,302,544Form 4
2026-09-04Krishnan SumaS (D)399$366.561,302,145Form 4
2026-09-04Krishnan SumaS (D)3,267$356.371,321,352Form 4
2026-08-14Rossi Dino AS (D)40$333.2350,000Form 4
2026-08-14Rossi Dino AS (D)3,095$331.4350,040Form 4
2026-08-14Rossi Dino AS (D)4,896$330.3653,135Form 4
2026-08-14Rossi Dino AS (D)7,428$329.658,031Form 4
2026-08-14Rossi Dino AS (D)1,687$328.5265,459Form 4
2026-08-14Rossi Dino AS (D)5,226$327.3967,146Form 4
2026-08-14Rossi Dino AS (D)2,287$326.672,372Form 4
2026-08-14Rossi Dino AS (D)341$325.674,659Form 4
2026-08-14Rossi Dino AG (D)3,691$075,000Form 4

Transaction codes in this quarter

S: 34G: 1

Get KRYS insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1711279&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · KRYS company page · Krystal Biotech, Inc. on SEC.gov

Questions

Are insiders buying or selling Krystal Biotech, Inc. (KRYS)?

In Q3 2026, insiders at Krystal Biotech, Inc. reported 35 non-derivative transactions on 9 Forms 3, 4 and 5: 0 open-market purchases and 34 sales worth $26.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Krystal Biotech, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/krys.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.